Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
LowReport
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $35.00.
MediumReport
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $35.00.
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Piper Sandler. They now have a $48.00 price target on the stock, down previously from $65.00.
NeutralReport
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Piper Sandler. They now have a $48.00 price target on the stock, down previously from $65.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: